MedChem 2018 is a conference dedicated to New Avenues in Kinase Drug Discovery.
MedChem 2018 covers topics such as:
- Chemoinformatics-Driven View of Kinase Drug Discovery
- Fragment Based Drug Discovery of Selective Inhibitors of Fibroblast Growth Factor Receptors
- PTEFb/CDK9 Inhibitor BAY 1251152 for the Treatment of Cancer
- CDK8 Inhibitors with Pre-Engineered Long Residence Time: From Design to Tumor Xenograft Models
- Development and In Vivo Profiling of a Novel Class of Immunosuppressive PI4KIIIβ Lipid Kinase Inhibitors
- Discovery